Lake Street Private Wealth’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-2,787
Closed -$216K – 299
2023
Q1
$216K Sell
2,787
-215
-7% -$16.6K 0.04% 258
2022
Q4
$233K Sell
3,002
-2,237
-43% -$165K 0.05% 245
2022
Q3
$352K Buy
5,239
+421
+9% +$31K 0.08% 198
2022
Q2
$370K Buy
+4,818
New +$376K 0.08% 203

Other funds holding PPH

Lake Street Private Wealth's PPH Position: Q2 2023 in Review

Lake Street Private Wealth sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 2,787 shares — an estimated $216K sold.

Lake Street Private Wealth first reported a position in PPH in Q2 2022 and held it in 4 quarters. The position peaked at $370K in Q2 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

  • Lake Street Private Wealth reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
  • Lake Street Private Wealth sold 2,787 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $216K.
  • Lake Street Private Wealth first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 4 quarters.
  • Lake Street Private Wealth's VanEck Pharmaceutical ETF position peaked at $370K in Q2 2022.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on Lake Street Private Wealth's 13F filing for Q2 2023, filed 18 Jul 2023.